C.R.I.T.
Technology
Platform

C.R.I.T.
Technology

Platform

C.R.I.T.

■ Hansford Biotech is developing a range of technologies to prevent and manage human disease through nutritional regulation.
A global market of strategic interest to food, health, and wellbeing companies, targeted nutrition, and human microbiome nutrition is forecast to become one of the world’s fastest growth areas.

■ Products developed through the C.R.I.T. Technology Platform platform are designed to improve consumer health and wellbeing and support the prevention and management of chronic lifestyle disorders.
These markets have enormous potential driven by macro-environmental factors, including an aging population, rising medical costs, a public health policy shift towards disease prevention, and consumer trends towards healthier lifestyles, better nutrition, and self-help.

C.R.I.T. Technology Platform  has developed three main research directions to identify and develop product technologies in various fields.
We can create new product concepts through the composition of different products within the platform.

C.R.I.T. Technology Platform

Hansford Biotech is developing a range of technologies to prevent and manage human disease through nutritional regulation. A global market of strategic interest to food, health, and wellbeing companies, targeted nutrition, and human microbiome nutrition is forecast to become one of the world’s fastest growth areas.

Products developed through the C.R.I.T. Technology Platform platform are designed to improve consumer health and wellbeing and support the prevention and management of chronic lifestyle disorders.
These markets have enormous potential driven by macro-environmental factors, including an aging population, rising medical costs, a public health policy shift towards disease prevention, and consumer trends towards healthier lifestyles, better nutrition, and self-help.

C.R.I.T. Technology Platform has developed three main research directions to identify and develop product technologies in various fields.
We can create new product concepts through the composition of different products within the platform.

C.R.I.T. 翰斯福技術平台 C.R.I.T. Technology Platform

Innovative Ingredients Research

C.R.I.T. 翰斯福技術平台 C.R.I.T. Technology Platform

Innovative Ingredients Research

Our Nutrition Ingredient Research Centre focuses on exploring and identifying new bioactivator and ingredients that can be developed into innovative, sustainable, and efficacious nutritional solutions.

We have searched for new and unique ingredients so that our customers can be truly innovative. Each new ingredient is backed by scientific research, guaranteed quality, and unparalleled customer service. In addition to new ingredients, we will also use our proprietary technology to improve the properties, flavors, and efficacy of existing ingredients in the market, so that our customers have more choices.

C.R.I.T. 翰斯福技術平台 C.R.I.T. Technology Platform

Targeted Nutrition                      

C.R.I.T. 翰斯福技術平台 C.R.I.T. Technology Platform

Targeted Nutrition        

Targeted nutrition is a personalized approach to nutritional products and dietary guidance to create behavioral change toward more healthy and tailored diets as well as optimized for the individual. Special medical or dietary needs can also be taken into account when creating targeted nutrition products for vulnerable groups and consumers.

Targeted nutrition innovation presents promising opportunities for consumers. We use screening and optimization techniques to create targeted nutritional regulators that provide more effective solutions for different demanding functions.

C.R.I.T. 翰斯福技術平台 C.R.I.T. Technology Platform

               Human Microbiome Nutrition

C.R.I.T. 翰斯福技術平台 C.R.I.T. Technology Platform

Human Microbiome Nutrition

The human digestive tract contains a complex and diverse ecosystem of microorganisms, mainly bacteria, of trillions. Recent advances in molecular and analytical techniques have permitted the identification of bacterial species and strains that inhabit the gastrointestinal tract, their metabolic activity, and interactions with the human host. These studies have provided greater insight into the role of gut microbes and their metabolites in health and disease.

There is a continuing increase in awareness and understanding of the microbiome from consumers, government, and media. This has led to growth forecasts for the human microbiome products market of a CAGR of 22.3% with commentators describing the opportunities open to microbiome development companies as being in the region of a trillion dollars.

By screening to identify and/or develop microbiome modifiers that can be used in proprietary formulations for the prevention, management, and wide range of chronic lifestyle diseases.

© 2021 Copyright - 翰斯福生技有限公司
- made by bouncin
error: Content is protected !!